Current Edition

A World Leader in Naturally Derived Products Discusses
Volume 13 Issue 2

A World Leader in Naturally Derived Products Discusses Commercial Success and New Innovations

Mr. Darren Alkins CEO at SPL – Scientific Protein Laboratories, speaks with IPI about their continued development in their science and technical expertise to meet …

Continue Reading →
How Technology Can Help Build a Fairer
Volume 13 Issue 2

How Technology Can Help Build a Fairer, Healthier World

Over the past couple of years, how we live our lives and do business have both fundamentally and irrevocably shifted. Richard Ettl at SkyCell explains …

Continue Reading →
The EU Medical Devices Regulation and its Market
Volume 13 Issue 2

The EU Medical Devices Regulation and its Market Impact Under the Spotlight

The global drug-device combination products market was estimated to be worth US$ 123.5 billion in 2020 and is forecast to grow at a CAGR of …

Continue Reading →
Digital Technology for Building Resilient Healthcare
Volume 13 Issue 2

Digital Technology for Building Resilient Healthcare Systems in Thailand and Southeast Asia

The healthcare systems in Southeast Asia are at a critical juncture today. The new wave of COVID-19 infections is straining healthcare facilities as cases continue …

Continue Reading →
Multifactorial Disease Models_ Their Role in De-risking
Volume 13 Issue 2

Multifactorial Disease Models: Their Role in De-risking Topical Formulation Development

A company’s attitude towards risk fundamentally affects their product development strategy, which can vary between the development of a simple or prototype formulation or a …

Continue Reading →
Compartmentalised Microfluidic Devices for Drug
Volume 13 Issue 2

Compartmentalised Microfluidic Devices for Drug Discovery in the Neurosciences

Neurological disorders are incredibly complex, and this is reflected in the lack of knowledge of the underlying pathological mechanism for many of these diseases, and …

Continue Reading →
Time to Put the Spotlight on the Substance of your Drugs
Volume 13 Issue 2

Time to Put the Spotlight on the Substance of your Drugs through Solid-form Development

The global pharmaceutical industry generated more than $1.25tr in revenue in 2019, up from $1.2tr in 2018, and the final figures for 2020 are expected …

Continue Reading →
Accelerating Pharma Research with Sensitive Spatial
Volume 13 Issue 2

Accelerating Pharma Research with Sensitive Spatial Analysis of Challenging Molecules

To reduce attrition rates in pharmaceutical research and development (R&D), powerful quantitative analytical methods are needed to monitor therapeutic compounds, their metabolites, and target engagement. …

Continue Reading →
How Endotoxin Contamination Can Affect Gene
Volume 13 Issue 2

How Endotoxin Contamination Can Affect Gene and Cell Therapies

Gene therapy is revolutionising the way we treat human diseases. Any technique that modifies a person’s genes to treat or cure a disease is considered …

Continue Reading →
Choosing the ‘Right’ Device to Deliver Your New Therapy
Volume 13 Issue 2

Choosing the ‘Right’ Device to Deliver Your New Therapy: Four Simple Steps

When you develop a new therapy, the device you develop or select to deliver will be a key to the overall success of your product. …

Continue Reading →